公开(公告)号：WO2008011337A1

公开(公告)日：2008-01-24

申请号：PCT/US2007/073422

申请日：2007-07-13

Applicant: ABBOTT LABORATORIES ,  WAGNER, Rolf ,  DONNER, Pamela L. ,  KEMPF, Dale J. ,  MARING, Clarence J. ,  STOLL, Vincent S. ,  KU, Yi-yin ,  PU, Yu-ming

Inventor： WAGNER, Rolf ,  DONNER, Pamela L. ,  KEMPF, Dale J. ,  MARING, Clarence J. ,  STOLL, Vincent S. ,  KU, Yi-yin ,  PU, Yu-ming

IPC: C07D495/04 ,  A61K31/505 ,  A61P31/12

CPC classification number: C07D495/04

Abstract: The present invention provides HCV polymerase inhibiting compounds having the formula (I) where R 1 is cyclobutyl-N(R a )-, n is 1, 2, 3 or 4, and at least one R 5 is R a SO 2 N(R j )alkyl-. In a non-limiting example, a compound of the present invention is N-[(3-{1-[(cyclobutyl)amino]-4-hydroxy-2-oxo-1,2-dihydro-quinolin-3-yl}-1,1-dioxo-1,4-dihydro-1?λ 6 -thieno[2,3-e][1,2,4]thiadiazin-7-yl)meth yl]methane-sulfonamide. The present invention also features compositions comprising the compounds of the present invention or pharmaceutically acceptable salts, stereoisomers or tautomers thereof, and methods of using the same to treat or prevent HCV infection.

Abstract translation: 本发明提供具有式（I）的HCV聚合酶抑制化合物，其中R 1是

公开(公告)号：WO2007103670A2

公开(公告)日：2007-09-13

申请号：PCT/US2007/062906

申请日：2007-02-27

Applicant: ABBOTT LABORATORIES ,  KEMPF, Dale J. ,  FLENTGE, Charles A. ,  RANDOLPH, John T. ,  HUANG, Peggy ,  KLEIN, Larry L.

Inventor： KEMPF, Dale J. ,  FLENTGE, Charles A. ,  RANDOLPH, John T. ,  HUANG, Peggy ,  KLEIN, Larry L.

IPC: A61K31/427 ,  A61K31/426 ,  C07D417/02 ,  C07D277/38

CPC classification number: C07D277/30 ,  A61K31/426 ,  A61K31/427 ,  A61K45/06 ,  C07C53/18 ,  C07D213/30 ,  C07D231/12 ,  C07D233/64 ,  C07D263/32 ,  C07D277/24 ,  C07D277/38 ,  C07D277/587 ,  C07D333/16 ,  C07D417/04

Abstract: Novel compounds of formula I, or a pharmaceutically acceptable salt thereof inhibit cytochrome P450 monooxygenase.

Abstract translation: 式I的新化合物或其药学上可接受的盐抑制细胞色素P450单加氧酶。

公开(公告)号：EP0674513B1

公开(公告)日：1996-09-25

申请号：EP94905429.0

申请日：1993-12-16

Applicant: ABBOTT LABORATORIES

Inventor： KEMPF, Dale J. ,  NORBECK, Daniel W. ,  SHAM, Hing Leung ,  ZHAO, Chen ,  SOWIN, Thomas J. ,  RENO, Daniel S. ,  HAIGHT, Anthony R. ,  COOPER, Arthur J.

IPC: A61K31/425 ,  A61K31/42 ,  C07D277/24 ,  C07D275/02 ,  C07D261/08 ,  C07D263/32 ,  C07F5/02 ,  C07D417/12 ,  C07D413/12 ,  C07D277/28 ,  C07D277/42

CPC classification number: C07D413/12 ,  A61K31/425 ,  A61K31/427 ,  A61K31/70 ,  A61K38/00 ,  A61K45/06 ,  C07C33/46 ,  C07C43/164 ,  C07C43/1742 ,  C07C43/2055 ,  C07C43/215 ,  C07C43/23 ,  C07C43/30 ,  C07C43/315 ,  C07C45/004 ,  C07C45/29 ,  C07C45/567 ,  C07C45/62 ,  C07C45/673 ,  C07C45/74 ,  C07C53/134 ,  C07C69/34 ,  C07C69/65 ,  C07C69/732 ,  C07C211/27 ,  C07C215/18 ,  C07C215/20 ,  C07C215/28 ,  C07C229/08 ,  C07C229/26 ,  C07C229/34 ,  C07C233/36 ,  C07C233/40 ,  C07C235/10 ,  C07C235/12 ,  C07C235/34 ,  C07C235/78 ,  C07C237/10 ,  C07C237/20 ,  C07C237/22 ,  C07C239/10 ,  C07C239/18 ,  C07C239/20 ,  C07C247/10 ,  C07C251/40 ,  C07C271/20 ,  C07C271/22 ,  C07C271/34 ,  C07C275/16 ,  C07C275/24 ,  C07C311/03 ,  C07C311/13 ,  C07C311/18 ,  C07C317/10 ,  C07C317/28 ,  C07C317/44 ,  C07C323/12 ,  C07C323/25 ,  C07C381/00 ,  C07D213/26 ,  C07D213/30 ,  C07D213/34 ,  C07D213/40 ,  C07D213/54 ,  C07D213/56 ,  C07D213/61 ,  C07D213/75 ,  C07D231/12 ,  C07D233/56 ,  C07D233/64 ,  C07D233/84 ,  C07D235/14 ,  C07D235/16 ,  C07D239/26 ,  C07D241/12 ,  C07D249/08 ,  C07D261/08 ,  C07D263/32 ,  C07D277/24 ,  C07D277/28 ,  C07D277/30 ,  C07D277/34 ,  C07D277/36 ,  C07D277/40 ,  C07D277/42 ,  C07D277/56 ,  C07D295/13 ,  C07D295/205 ,  C07D295/215 ,  C07D303/36 ,  C07D307/42 ,  C07D333/16 ,  C07D401/12 ,  C07D417/12 ,  C07K5/06026 ,  C07K5/06078 ,  A61K31/00 ,  A61K2300/00 ,  C07C49/233 ,  C07C49/255 ,  C07C49/215 ,  C07C49/245 ,  C07C49/235 ,  C07C49/223

Abstract: A retroviral protease inhibiting compound of formula (A) is disclosed for use in combination with other active pharmaceutical agents for treating a human infected by HIV. Intermediates and processes useful in the manufacture of compounds of formula (A) are also disclosed.

公开(公告)号：EP1979349B1

公开(公告)日：2010-07-28

申请号：EP06848056.5

申请日：2006-12-20

Applicant: ABBOTT LABORATORIES

Inventor： ROCKWAY, Todd W. ,  BETEBENNER, David A. ,  KRUEGER, Allan C. ,  IWASAKI, Nobuhiko ,  COOPER, Curt S. ,  ANDERSON, David D. ,  KEMPF, Dale J. ,  MADIGAN, Darold L. ,  MOTTER, Christopher E. ,  SHANLEY, Jason P. ,  TUFANO, Michael D. ,  WAGNER, Rolf ,  ZHANG, Rong ,  MOLLA, Akhteruzzaman ,  MO, Hongmei ,  PILOT-MATIAS, Tami ,  MASSE, Sherie VL. ,  CARRICK, Robert J. ,  HE, Weping ,  LU, Liangjun

IPC: C07D471/04

CPC classification number: C07D471/04

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus ('HCV') or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

公开(公告)号：EP1979349A2

公开(公告)日：2008-10-15

申请号：EP06848056.5

申请日：2006-12-20

Applicant: ABBOTT LABORATORIES

Inventor： ROCKWAY, Todd W. ,  BETEBENNER, David A. ,  KRUEGER, Allan C. ,  IWASAKI, Nobuhiko ,  COOPER, Curt S. ,  ANDERSON, David D. ,  KEMPF, Dale J. ,  MADIGAN, Darold L. ,  MOTTER, Christopher E. ,  SHANLEY, Jason P. ,  TUFANO, Michael D. ,  WAGNER, Rolf ,  ZHANG, Rong ,  MOLLA, Akhteruzzaman ,  MO, Hongmei ,  PILOT-MATIAS, Tami ,  MASSE, Sherie VL. ,  CARRICK, Robert J. ,  HE, Weping ,  LU, Liangjun

IPC: C07D471/04

CPC classification number: C07D471/04

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus ('HCV') or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

公开(公告)号：EP1358154A2

公开(公告)日：2003-11-05

申请号：EP00972042.6

申请日：2000-10-10

Applicant: Abbott Laboratories

Inventor： MARING, Clarence J. ,  GIRANDA, Vincent L. ,  KEMPF, Dale J. ,  STOLL, Vincent S. ,  SUN, Minghua ,  ZHAO, Chen ,  GU, Yu Gui ,  HANESSIAN, Stephen ,  WANG, Gary T. ,  KRUEGER, Allan C. ,  CHEN, Hui-Ju ,  CHEN, Yuanwei ,  DEGOEY, David A. ,  FLOSI, William J. ,  GRAMPOVNIK, David J. ,  KATI, Warren M. ,  KENNEDY, April L. ,  KLEIN, Larry L. ,  LIN, Zhen ,  MADIGAN, Darold L. ,  MCDANIEL, Keith F. ,  MUCHMORE, Steven W. ,  SHAM, Hing L. ,  STEWART, Kent D. ,  TU, Noah P. ,  WAGENAAR, Frank L. ,  WANG, Sheldon ,  WIEDEMAN, Paul E. ,  XU, Yibo ,  YEUNG, Ming C. ,  BAYRAKDARIAN, Malken ,  LUO, Xuehong

IPC: C07D207/16 ,  C07D403/04 ,  C07D417/04

CPC classification number: C07D207/16 ,  C07D207/26 ,  C07D207/327 ,  C07D207/38 ,  C07D207/46 ,  C07D231/12 ,  C07D233/56 ,  C07D249/08 ,  C07D303/16 ,  C07D403/04 ,  C07D405/04 ,  C07D405/06 ,  C07D409/06 ,  C07D413/04 ,  C07D417/04 ,  C07D417/06

Abstract: Enantiomerically enriched compounds having the absolute stereochemistry of the formula (I) or a pharmaceutically acceptable salt, ester or prodrug thereof, which are useful for inhibiting neuraminidases from disease-causing microorganisms, especially, influenza neuraminidase. Also disclosed are compositions and methods for preventing and treating diseases caused by microorganisms having a neuraminidase, processes for preparing the compounds and synthetic intermediates used in these processes.

公开(公告)号：EP1993820A2

公开(公告)日：2008-11-26

申请号：EP07757576.9

申请日：2007-02-27

Applicant: ABBOTT LABORATORIES

Inventor： KEMPF, Dale J. ,  FLENTGE, Charles A. ,  RANDOLPH, John T. ,  HUANG, Peggy ,  KLEIN, Larry L.

IPC: B29D31/00 ,  D01D5/00

CPC classification number: C07D277/30 ,  A61K31/426 ,  A61K31/427 ,  A61K45/06 ,  C07C53/18 ,  C07D213/30 ,  C07D231/12 ,  C07D233/64 ,  C07D263/32 ,  C07D277/24 ,  C07D277/38 ,  C07D277/587 ,  C07D333/16 ,  C07D417/04

Abstract: Novel compounds of formula I, or a pharmaceutically acceptable salt thereof inhibit cytochrome P450 monooxygenase.

公开(公告)号：EP0674513A1

公开(公告)日：1995-10-04

申请号：EP94905429.0

申请日：1993-12-16

Applicant: ABBOTT LABORATORIES

Inventor： KEMPF, Dale J. ,  NORBECK, Daniel W. ,  SHAM, Hing Leung ,  ZHAO, Chen ,  SOWIN, Thomas J. ,  RENO, Daniel S. ,  HAIGHT, Anthony R. ,  COOPER, Arthur J.

IPC: C07D ,  C07D275 ,  A61K31 ,  A61K45 ,  A61P31 ,  A61P35 ,  A61P37 ,  A61P43 ,  C07C33 ,  C07C43 ,  C07C45 ,  C07C53 ,  C07C69 ,  C07C211 ,  C07C215 ,  C07C229 ,  C07C233 ,  C07C235 ,  C07C237 ,  C07C239 ,  C07C247 ,  C07C251 ,  C07C271 ,  C07C275 ,  C07C311 ,  C07C317 ,  C07C323 ,  C07C381 ,  C07D213 ,  C07D233 ,  C07D235 ,  C07D239 ,  C07D241 ,  C07D261 ,  C07D263 ,  C07D265 ,  C07D277 ,  C07D295 ,  C07D303 ,  C07D307 ,  C07D333 ,  C07D401 ,  C07D413 ,  C07D417 ,  C07D521 ,  C07F5 ,  C07K5 ,  A61K38

CPC classification number: C07D413/12 ,  A61K31/425 ,  A61K31/427 ,  A61K31/70 ,  A61K38/00 ,  A61K45/06 ,  C07C33/46 ,  C07C43/164 ,  C07C43/1742 ,  C07C43/2055 ,  C07C43/215 ,  C07C43/23 ,  C07C43/30 ,  C07C43/315 ,  C07C45/004 ,  C07C45/29 ,  C07C45/567 ,  C07C45/62 ,  C07C45/673 ,  C07C45/74 ,  C07C53/134 ,  C07C69/34 ,  C07C69/65 ,  C07C69/732 ,  C07C211/27 ,  C07C215/18 ,  C07C215/20 ,  C07C215/28 ,  C07C229/08 ,  C07C229/26 ,  C07C229/34 ,  C07C233/36 ,  C07C233/40 ,  C07C235/10 ,  C07C235/12 ,  C07C235/34 ,  C07C235/78 ,  C07C237/10 ,  C07C237/20 ,  C07C237/22 ,  C07C239/10 ,  C07C239/18 ,  C07C239/20 ,  C07C247/10 ,  C07C251/40 ,  C07C271/20 ,  C07C271/22 ,  C07C271/34 ,  C07C275/16 ,  C07C275/24 ,  C07C311/03 ,  C07C311/13 ,  C07C311/18 ,  C07C317/10 ,  C07C317/28 ,  C07C317/44 ,  C07C323/12 ,  C07C323/25 ,  C07C381/00 ,  C07D213/26 ,  C07D213/30 ,  C07D213/34 ,  C07D213/40 ,  C07D213/54 ,  C07D213/56 ,  C07D213/61 ,  C07D213/75 ,  C07D231/12 ,  C07D233/56 ,  C07D233/64 ,  C07D233/84 ,  C07D235/14 ,  C07D235/16 ,  C07D239/26 ,  C07D241/12 ,  C07D249/08 ,  C07D261/08 ,  C07D263/32 ,  C07D277/24 ,  C07D277/28 ,  C07D277/30 ,  C07D277/34 ,  C07D277/36 ,  C07D277/40 ,  C07D277/42 ,  C07D277/56 ,  C07D295/13 ,  C07D295/205 ,  C07D295/215 ,  C07D303/36 ,  C07D307/42 ,  C07D333/16 ,  C07D401/12 ,  C07D417/12 ,  C07K5/06026 ,  C07K5/06078 ,  A61K31/00 ,  A61K2300/00 ,  C07C49/233 ,  C07C49/255 ,  C07C49/215 ,  C07C49/245 ,  C07C49/235 ,  C07C49/223

Abstract: A retroviral protease inhibiting compound of formula (A) is disclosed for use in combination with other active pharmaceutical agents for treating a human infected by HIV. Intermediates and processes useful in the manufacture of compounds of formula (A) are also disclosed.